KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTS · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2021 | |
|---|---|---|---|---|
| Market Cap | $1,192 | $1,082 | $1,082 | $1,082 |
| - Cash | $238 | $8 | $15 | $24 |
| + Debt | $44 | $45 | $39 | $23 |
| Enterprise Value | $998 | $1,119 | $1,106 | $1,080 |
| Revenue | $60 | $28 | $8 | $0 |
| % Growth | 115.1% | 264.5% | – | – |
| Gross Profit | $24 | $0 | -$11 | $0 |
| % Margin | 40.5% | 1.3% | -139.6% | – |
| EBITDA | -$98 | -$76 | -$74 | -$32 |
| % Margin | -163.8% | -274.3% | -966.4% | – |
| Net Income | -$114 | -$94 | -$84 | -$34 |
| % Margin | -190.3% | -338.4% | -1,104% | – |
| EPS Diluted | -5.13 | -2.04 | -1.75 | -0.69 |
| % Growth | -151.5% | -16.6% | -153.6% | – |
| Operating Cash Flow | -$78 | -$72 | -$70 | -$30 |
| Capital Expenditures | -$24 | -$13 | -$15 | -$0 |
| Free Cash Flow | -$101 | -$85 | -$85 | -$30 |